• Colorectal cancer: $281 million
• Crohn’s disease: $61 million
• Digestive diseases (general): $1.58 billion
• Digestive diseases (gallbladder): $10 million
• Digestive diseases (peptic ulcer): $19 million
More Articles on Gastroenterology:
ASCA, U.S. Rep. Charlie Dent Partner to Promote Colorectal Cancer Screening
7 Gastroenterologists on Benchmarking & Colonoscopy Quality (Part 2)
Covenant Endoscopy Center to Offer Free Colonoscopy Screenings
